Tacrolimus ointment for the treatment of atopic dermatitis
Boucher M
Record ID 32001000957
English, French
Authors' objectives:
To summarise the available evidence on the use of tacrolimus ointment for the treatment of atopic dermatitis.
Authors' recommendations:
- Atopic dermatitis (AD) is a chronic dermatological condition characterized by pruritus (itchiness) and rash. Topical corticosteroids are the mainstay of pharmacotherapy.
- Tacrolimus ointment is a new topical anti-inflammatory agent available in Canada through the Special Access Program.
- It is approved as a second line agent for short or long term intermittent treatment of moderate to severe AD.
- Clinical trials suggest it is both effective and safe, but comparative studies with corticosteroids and long-term information are limited.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/research/index.html
Year Published:
2001
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Anti-Inflammatory Agents
- Dermatitis, Atopic
- Eczema
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.